The following miRNA-target pairs, validated by luciferase reporter experiments, were extracted manually from the corresponding reference. A few target genes not documented here may be available in "TarBase" and "miRecords" database system. miRNA Validated target Pub Date Reference hsa-let-7a KRAS 2008 A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. hsa-let-7a HMGA2 2008 Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. hsa-let-7a integrin beta(3) 2008 Integrin beta(3) expression is regulated by let-7a miRNA in malignant melanoma. hsa-let-7a caspase-3 2008 Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. hsa-let-7a PRDM1/Blimp-1 2008 MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. hsa-let-7a HMGA2 2007 Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. hsa-let-7a IGF-II 2007 Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. hsa-let-7a HMGA2 2007 Let-7 expression defines two differentiation stages of cancer. hsa-let-7a HMGA2 2007 let-7 regulates self renewal and tumorigenicity of breast cancer cells. hsa-let-7a RAS 2007 let-7 regulates self renewal and tumorigenicity of breast cancer cells. hsa-let-7a BCL2 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. hsa-let-7a RAS 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. hsa-let-7a MYC 2007 MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. hsa-let-7a CDC25A 2007 The let-7 microRNA represses cell proliferation pathways in human cells. hsa-let-7a CDK6 2007 The let-7 microRNA represses cell proliferation pathways in human cells. hsa-let-7a NF2 2007 The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. hsa-let-7a c-myc 2006 let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7a RAS 2006 let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7a RAS 2005 RAS is regulated by the let-7 microRNA family. hsa-let-7a NIRF 2009 Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells hsa-let-7b Cdc34 2009 let-7 overexpression leads to an increased fraction of cells in G2/M, direct down-regulation of Cdc34 and stabilization of Wee1 kinase in primary fibroblasts. hsa-let-7b Dicer 2008 A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence hsa-let-7b KRAS 2008 A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. hsa-let-7b CCND1 2008 MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. hsa-let-7b CDC25A 2007 The let-7 microRNA represses cell proliferation pathways in human cells. hsa-let-7b CDK6 2007 The let-7 microRNA represses cell proliferation pathways in human cells. hsa-let-7b HMGA2 2007 The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. hsa-let-7c HMGA2 2008 Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. hsa-let-7c HMGA2 2007 A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. hsa-let-7c HMGA2 2007 Let-7 expression defines two differentiation stages of cancer. hsa-let-7c BCL2 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. hsa-let-7c RAS 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. hsa-let-7c CDC25A 2007 The let-7 microRNA represses cell proliferation pathways in human cells. hsa-let-7c CDK6 2007 The let-7 microRNA represses cell proliferation pathways in human cells. hsa-let-7c RAS 2007 Widespread deregulation of microRNA expression in human prostate cancer. hsa-let-7d KRAS 2008 A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. hsa-let-7d HMGA2 2007 Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. hsa-let-7d BCL2 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. hsa-let-7d RAS 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. hsa-let-7d CDC25A 2007 The let-7 microRNA represses cell proliferation pathways in human cells. hsa-let-7d CDK6 2007 The let-7 microRNA represses cell proliferation pathways in human cells. hsa-let-7d BDNF 2009 microRNAs miR-124, let-7d and miR-181a regulate Cocaine-induced Plasticity hsa-let-7d D3R 2009 microRNAs miR-124, let-7d and miR-181a regulate Cocaine-induced Plasticity hsa-let-7e HMGA2 2007 The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. hsa-let-7g KRAS 2008 A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. hsa-let-7g HMGA2 2008 Suppression of non-small cell lung tumor development by the let-7 microRNA family. hsa-let-7g Ras 2008 Suppression of non-small cell lung tumor development by the let-7 microRNA family. hsa-let-7g HMGA2 2007 Let-7 expression defines two differentiation stages of cancer. hsa-let-7g CDC25A 2007 The let-7 microRNA represses cell proliferation pathways in human cells. hsa-let-7g CDK6 2007 The let-7 microRNA represses cell proliferation pathways in human cells. hsa-miR-1 c-Met 2009 MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. hsa-miR-1 calmodulin 2009 MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes hsa-miR-1 Gata4 2009 MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes hsa-miR-1 Mef2a 2009 MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes hsa-miR-1 BCL2 2009 MicroRNA-1 Regulates Cardiomyocyte Apoptosis by Targeting Bcl-2 hsa-miR-1 Gata4 2009 MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. hsa-miR-1 calmodulin 2009 Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3'untranslated region: a role for microRNA23b. hsa-miR-1 Mef2a 2009 Up-regulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1 (NAIP) in glioblastoma multiforme(GBM). hsa-miR-1 C/EBPa 2008 Downregulation of microRNA-1 (miR-1) in lung cancer: Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin induced apoptosis bymiR-1. hsa-miR-1 FoxP1 2008 Downregulation of microRNA-1 (miR-1) in lung cancer: Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin induced apoptosis bymiR-1. hsa-miR-1 HDAC4 2008 Downregulation of microRNA-1 (miR-1) in lung cancer: Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin induced apoptosis bymiR-1. hsa-miR-1 MET 2008 Downregulation of microRNA-1 (miR-1) in lung cancer: Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin induced apoptosis bymiR-1. hsa-miR-1 HCN4 2008 Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. hsa-miR-1 FoxP1 2008 Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. hsa-miR-1 HDAC4 2008 Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. hsa-miR-1 MET 2008 Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. hsa-miR-1 Cdk9 2008 MicroRNAs play an essential role in the development of cardiac hypertrophy. hsa-miR-1 fibronectin 2008 MicroRNAs play an essential role in the development of cardiac hypertrophy. hsa-miR-1 RasGAP 2008 MicroRNAs play an essential role in the development of cardiac hypertrophy. hsa-miR-1 Rheb 2008 MicroRNAs play an essential role in the development of cardiac hypertrophy. hsa-miR-1 MEF-2 2008 The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. hsa-miR-1 nAChR 2008 The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. hsa-miR-1 GAJ1 2007 The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. hsa-miR-1 KCNJ2 2007 The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. hsa-miR-1 HSP60 2007 The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. hsa-miR-1 HSP70 2007 The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. hsa-miR-1 Hand2 2005 Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. hsa-miR-1 Kir2.1 2009 Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1 hsa-miR-100 Plk1 2009 Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer hsa-miR-101 EZH2 2009 The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the polycomb group protein EZH2 in cancer hsa-miR-101 EZH2 2009 Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. hsa-miR-101 Mcl-1 2009 Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. hsa-miR-101 FOS 2009 MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. hsa-miR-101 EZH2 2009 The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. hsa-miR-101 FOS 2009 The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. hsa-miR-101 ATXN1 2008 miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. hsa-miR-101 MYCN 2007 MicroRNA signatures in human ovarian cancer. hsa-miR-101 Ezh2 2010 MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. hsa-miR-101b ATXN1 2009 Regulation of microRNA expression by HMGA1 proteins hsa-miR-101b STC1 2009 Regulation of microRNA expression by HMGA1 proteins hsa-miR-106a IL-10 2009 Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a hsa-miR-106a E2F1 2008 Deregulated expression of miR-106a predicts survival in human colon cancer patients. hsa-miR-106a Mylip 2006 Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. hsa-miR-106b p21 2009 Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. hsa-miR-106b APP 2009 MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. hsa-miR-106b Itch 2009 MicroRNA-regulated pathways associated with endometriosis. hsa-miR-106b E2F1 2009 Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. hsa-miR-106b E2F1 2008 E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. hsa-miR-106b PCAF 2008 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. hsa-miR-107 PLAG1 2009 miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. hsa-miR-107 BACE1 2008 The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. hsa-miR-10b HOXD10 2007 Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. hsa-miR-10b PPAR-alpha 2009 Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD hsa-miR-1-2 Hand2 2007 Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. hsa-miR-1-2 Irx5 2007 Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. hsa-miR-1-2 Kcnd2 2007 Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. hsa-miR-122 Bcl-w 2008 miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. hsa-miR-122 ADAM-10 2009 MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to Sorafenib hsa-miR-122 SRF 2009 MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to Sorafenib hsa-miR-122 Igf1R 2009 MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to Sorafenib hsa-miR-122a CCNG1 2009 MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. hsa-miR-122a CCNG1 2007 Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. hsa-miR-122a AMPK 2006 miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. hsa-miR-124 BDNF 2009 microRNAs miR-124, let-7d and miR-181a regulate Cocaine-induced Plasticity hsa-miR-124 D3R 2009 microRNAs miR-124, let-7d and miR-181a regulate Cocaine-induced Plasticity hsa-miR-124 Sox9 2009 miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche hsa-miR-124a Rb 2009 Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. hsa-miR-124a IkappaBzeta 2009 IkappaBzeta expression is regulated by miR-124a hsa-miR-124a CDK6 2008 miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. hsa-miR-124a CDK6 2008 Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. hsa-miR-124a CDK6 2007 CpG island hypermethylation of tumor suppressor microRNAs in human cancer. hsa-miR-124a CDK6 2007 Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. hsa-miR-125a TrkC 2009 Low-Level Expression of MicroRNAs let-7d and miR-205 Are Prognostic Markers of Head and Neck Squamous Cell Carcinoma. hsa-miR-125a TrkC 2008 MicroRNA profiling in human medulloblastoma. hsa-miR-125a ERBB2 2006 Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. hsa-miR-125a ERBB3 2006 Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. hsa-miR-125a p53 2009 MicroRNA 125a and its regulation of the p53 tumor suppressor gene hsa-miR-125a HuR 2009 MicroRNA-125a represses cell growth by targeting HuR in breast cancer hsa-miR-125a ARID3B 2009 The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells hsa-miR-125b VDR 2009 MicroRNA regulates human vitamin D receptor hsa-miR-125b p53 2009 MicroRNA-125b is a novel negative regulator of p53 hsa-miR-125b BAK1 2009 MicroRNAs and their potential for translation in prostate cancer. hsa-miR-125b CDK6 2009 MicroRNAs and their potential for translation in prostate cancer. hsa-miR-125b Gli1 2008 Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. hsa-miR-125b Bak1 2007 An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. hsa-miR-125b HMGA1 2007 Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. hsa-miR-125b HMGA2 2007 Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. hsa-miR-125b EIF4EBP1 2007 Widespread deregulation of microRNA expression in human prostate cancer. hsa-miR-125b ERBB2 2006 Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. hsa-miR-125b ERBB3 2006 Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. hsa-miR-125b BMPR1B 2009 A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis hsa-miR-126 IRS-1 2009 Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. hsa-miR-126 p85beta 2008 Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126 hsa-miR-126 PLK2 2008 Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. hsa-miR-126 CRK 2008 MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. hsa-miR-126 HOXA9 2008 MicroRNA-126 regulates HOXA9 by binding to the homeobox. hsa-miR-126 SPRED1 2008 miR-126 regulates angiogenic signaling and vascular integrity hsa-miR-126 p85beta 2008 The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. hsa-miR-126 p85beta 2008 The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. hsa-miR-126 Crk 2009 Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration hsa-miR-126* prostein 2007 Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. hsa-miR-127 BLIMP1 2009 B cell differentiation in EBV-positive Burkitt Lymphoma is impaired at post-transcriptional level by miRNA altered expression. hsa-miR-127 XBP1 2009 B cell differentiation in EBV-positive Burkitt Lymphoma is impaired at post-transcriptional level by miRNA altered expression. hsa-miR-127 BCL6 2008 Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. hsa-miR-127 BCL6 2007 CpG island hypermethylation of tumor suppressor microRNAs in human cancer. hsa-miR-127 BCL6 2006 Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. hsa-miR-128 DCX 2009 MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. hsa-miR-128 Reelin 2009 MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. hsa-miR-128 NTRK3 2009 Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. hsa-miR-128 E2F3a 2009 MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. hsa-miR-128 E2F3a 2008 MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. hsa-miR-128b EGFR 2008 EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. hsa-miR-128b MLL 2009 miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221 hsa-miR-128b AF4 2009 miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221 hsa-miR-128b MLL-AF4 2009 miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221 hsa-miR-128b AF4-MLL 2009 miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221 hsa-miR-129 GALNT1 2009 Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. hsa-miR-129 SOX4 2009 Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. hsa-miR-130 ATXN1 2008 miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. hsa-miR-130a FOG-2 2009 Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a hsa-miR-130b TP53INP1 2008 Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. hsa-miR-132 p250GAP 2007 A microRNA-based gene dysregulation pathway in Huntington's disease. hsa-miR-132 MeCP2 2009 MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis hsa-miR-132 p250GAP 2009 An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling hsa-miR-132 SirT1 2009 MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1 hsa-miR-133 KLF15 2009 MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes hsa-miR-133 KLF15 2009 MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes hsa-miR-133a KRT7 2009 Identification of novel microRNA targets based on microRNA signatures in bladder cancer. hsa-miR-133a UCP2 2009 In vitro evidence suggests that miR-133a-mediated regulation of uncoupling protein 2 (UCP2) is an indispensable step in myogenic differentiation hsa-miR-133a HCN2 2008 Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. hsa-miR-133a HCN4 2008 Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. hsa-miR-133a PKM2 2008 Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. hsa-miR-133a ERG 2007 MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. hsa-miR-133a Cdc42 2007 MicroRNA-133 controls cardiac hypertrophy. hsa-miR-133a Nelf-A/WHSC2 2007 MicroRNA-133 controls cardiac hypertrophy. hsa-miR-133a RhoA 2007 MicroRNA-133 controls cardiac hypertrophy. hsa-miR-133a Casp9 2007 The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. hsa-miR-133b Mcl-1 2009 MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. hsa-miR-133b BCL2L2 2009 MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. hsa-miR-133b IGF-IR 2009 MicroRNA regulation of neuron-like differentiation of adipose tissue-derived stem cells hsa-miR-133b PKM2 2008 Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. hsa-miR-133b Pitx3 2007 A MicroRNA feedback circuit in midbrain dopamine neurons. hsa-miR-135a JAK2 2009 Regulation of JAK2 by miR-135a: prognostic impact in classical Hodgkin lymphoma. hsa-miR-137 CDK6 2008 Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. hsa-miR-137 CDK6 2008 miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. hsa-miR-138 hTERT 2008 Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. hsa-miR-140 Cxcl12 2008 Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140 hsa-miR-140 HDAC4 2009 Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells hsa-miR-140* Dnm1 2008 Nicotine modulates expression of miR-140*, which targets the 3'-untranslated region of dynamin 1 gene ( Dnm1) hsa-miR-141 Dlx5 2009 MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse Pre-osteoblast differentiation by targeting distal-less homeobox 5 hsa-miR-141 ZEB1(deltaEF1) 2008 A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. hsa-miR-141 SIP1(ZEB2) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-141 ZEB1(deltaEF1) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-141 SIP1(ZEB2) 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. hsa-miR-141 ZEB1(deltaEF1) 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. hsa-miR-141 CLOCK 2006 Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. hsa-miR-141 SIP1 2009 MicroRNA-141 Regulates Smad Interacting Protein 1 (SIP1) and Inhibits Migration and Invasion of Colorectal Cancer Cells hsa-miR-141 ZEB1 2009 Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition hsa-miR-141 ZEB2 2009 Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition hsa-miR-142-3p AC9 2009 miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA hsa-miR-143 DNMT3A 2009 MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. hsa-miR-143 Klf4 2009 miR-145 and miR-143 regulate smooth muscle cell fate and plasticity hsa-miR-143 Elk-1 2009 miR-145 and miR-143 regulate smooth muscle cell fate and plasticity hsa-miR-143 KRAS 2009 Role of miR-143 targeting KRAS in colorectal tumorigenesis hsa-miR-143 ERK5 2009 Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. hsa-miR-143 KRAS 2009 Role of miR-143 targeting KRAS in colorectal tumorigenesis. hsa-miR-143 FNDC3B 2009 Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. hsa-miR-143 ERK5 2007 Downregulation of microRNAs-143 and -145 in B-cell malignancies. hsa-miR-143 ERK5 2007 Downregulation of microRNAs-143 and -145 in B-cell malignancies. hsa-miR-143 ERK5 2007 MicroRNA-143 and -145 in colon cancer. hsa-miR-143 ERK5 2006 MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. hsa-miR-143 ERK5 2004 MicroRNA-143 regulates adipocyte differentiation. hsa-miR-144 Klfd 2008 Mir-144 selectively regulates embryonic {alpha}-hemoglobin synthesis during primitive erythropoiesis. hsa-miR-145 Klf4 2009 miR-145 and miR-143 regulate smooth muscle cell fate and plasticity hsa-miR-145 Elk-1 2009 miR-145 and miR-143 regulate smooth muscle cell fate and plasticity hsa-miR-145 IGF-IR 2009 Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway. hsa-miR-145 IRS-1 2009 Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway. hsa-miR-145 KLF4 2009 MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells hsa-miR-145 SOX2 2009 MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells hsa-miR-145 KLF5 2009 MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation. hsa-miR-145 IRS-1 2007 Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. hsa-miR-145 BNIP3 2010 MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. hsa-miR-146a TRAF6 2009 MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2 hsa-miR-146a IRAK1 2009 MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2 hsa-miR-146a IRAK2 2009 MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2 hsa-miR-146a CFH 2009 Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. hsa-miR-146a BRCA1 2008 A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. hsa-miR-146a BRCA2 2008 A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. hsa-miR-146a CFH 2008 An NF-kB-sensitive microRNA-146a-mediated inflammatory circuit in Alzheimer's disease and in stressed human brain cells. hsa-miR-146a NF-kappaB 2008 Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. hsa-miR-146a ROCK1 2008 Loss of mir-146a function in hormone-refractory prostate cancer. hsa-miR-146a IRAK1 2006 NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. hsa-miR-146a TRAF6 2006 NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. hsa-miR-146a KIT 2005 The role of microRNA genes in papillary thyroid carcinoma. hsa-miR-146b MMP16 2009 microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. hsa-miR-146b NF-kappaB 2008 Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. hsa-miR-148a TGIF2 2008 A microRNA DNA methylation signature for human cancer metastasis hsa-miR-148a HLA-G 2007 Allele-specific targeting of microRNAs to HLA-G and risk of asthma. hsa-miR-148a DNMT-1 2010 MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. hsa-miR-148b HLA-G 2007 Allele-specific targeting of microRNAs to HLA-G and risk of asthma. hsa-miR-15 c-myb 2009 Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. hsa-miR-150 P2X7 2008 MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript hsa-miR-152 HLA-G 2007 Allele-specific targeting of microRNAs to HLA-G and risk of asthma. hsa-miR-152 DNMT-1 2010 MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. hsa-miR-153 Mcl-1 2009 Down-regulations of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1) by MicroRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. hsa-miR-153 BCL2 2009 Down-regulations of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1) by MicroRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. hsa-miR-155 SOCS1 2009 Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein hsa-miR-155 SHIP1 2009 Inositol phosphatase SHIP1 is a primary target of miR-155 hsa-miR-155 TAB2 2009 MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells hsa-miR-155 AGTR1 2008 Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. hsa-miR-155 Ets-1 2008 MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors hsa-miR-155 Meis1 2008 MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors hsa-miR-155 RhoA 2008 MicroRNA-155 Is Regulated by TGF{beta}/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA hsa-miR-155 RhoA 2008 MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. hsa-miR-155 TP53INP1 2007 Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. hsa-miR-155 hAT1R 2006 MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. hsa-miR-155 ET-1 2009 Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199 hsa-miR-155 JARID2 2009 Reticuloendotheliosis virus strain T induces miR-155 which targets JARID2 and promotes cell survival hsa-miR-155 KGF 2009 Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions hsa-miR-15a CCND1 2009 miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. hsa-miR-15a CCND2 2009 miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. hsa-miR-15a CCNE1 2009 miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. hsa-miR-15a CCND1 2009 miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. hsa-miR-15a CCND2 2009 miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. hsa-miR-15a CCNE1 2009 miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. hsa-miR-15a CCND1 2009 miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non-Small Cell Lung Cancer. hsa-miR-15a Cdc25A 2008 MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. hsa-miR-15a Myb 2008 The c-myb Protooncogene and microRNA (miR)-15a comprise an active autoregulatory feedback loop in human hematopoietic cells hsa-miR-15a CCND1 2008 The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. hsa-miR-15a WNT3A 2008 The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. hsa-miR-15a BCL2 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. hsa-miR-15a RAS 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. hsa-miR-15a BCL2 2007 The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. hsa-miR-15a BCL2 2005 miR-15 and miR-16 induce apoptosis by targeting BCL2. hsa-miR-15a RAS 2005 miR-15a and miR-16-1 down-regulation in pituitary adenomas. hsa-miR-15a BMI1 2009 MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. hsa-miR-15b CCNE1 2009 MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. hsa-miR-15b BCL2 2009 miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis hsa-miR-15b caspases-3 2009 miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis hsa-miR-15b caspases-8 2009 miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis hsa-miR-15b caspases-9 2009 miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis hsa-miR-15b CCNE1 2009 miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. hsa-miR-15b BCL2 2008 miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. hsa-miR-15b eIF-4A 2006 Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. hsa-miR-16 BCL2 2009 Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. hsa-miR-16 CCND1 2009 miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non-Small Cell Lung Cancer. hsa-miR-16 BCL2 2009 miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis hsa-miR-16 caspases-3 2009 miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis hsa-miR-16 caspases-8 2009 miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis hsa-miR-16 caspases-9 2009 miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis hsa-miR-16 Caprin-1 2009 Two new miR-16 targets: Caprin-1 and HMGA1, proteins implicated in cell proliferation hsa-miR-16 HMGA1 2009 Two new miR-16 targets: Caprin-1 and HMGA1, proteins implicated in cell proliferation hsa-miR-16 BCL2 2008 miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. hsa-miR-16 CCND1 2008 miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes hsa-miR-16 CCND3 2008 miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes hsa-miR-16 CCNE1 2008 miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes hsa-miR-16 CDK6 2008 miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes hsa-miR-16 CCND1 2008 Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. hsa-miR-16 BCL2 2007 Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. hsa-miR-16 BCL2 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. hsa-miR-16 RAS 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. hsa-miR-16 BCL2 2007 The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. hsa-miR-16 BCL2 2005 miR-15 and miR-16 induce apoptosis by targeting BCL2. hsa-miR-16 RAS 2005 miR-15a and miR-16-1 down-regulation in pituitary adenomas. hsa-miR-16 RARS 2002 Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. hsa-miR-16 CDK1 2009 Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes hsa-miR-16 CDK2 2009 Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes hsa-miR-16 BMI1 2009 MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. hsa-miR-16-1 CCND1 2008 The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. hsa-miR-16-1 WNT3A 2008 The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. hsa-miR-16a BCL2 2008 Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. hsa-miR-17 E2F1 2009 miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression hsa-miR-17 CDKN1A 2008 MicroRNA-17-92 downregulates expression of distinct targets in different B-cell lymphoma subtypes. hsa-miR-17 p21 2008 MicroRNA-17-92 downregulates expression of distinct targets in different B-cell lymphoma subtypes. hsa-miR-17 YES1 2009 A high throughput experimental approach to identify miRNA targets in human cells hsa-miR-17 RBJ 2009 A high throughput experimental approach to identify miRNA targets in human cells hsa-miR-17 NPAT 2009 A high throughput experimental approach to identify miRNA targets in human cells hsa-miR-17 FBX031 2009 A high throughput experimental approach to identify miRNA targets in human cells hsa-miR-17 OBFC2A 2009 A high throughput experimental approach to identify miRNA targets in human cells hsa-miR-17 GPR137B 2009 A high throughput experimental approach to identify miRNA targets in human cells hsa-miR-17 CCL1 2009 A high throughput experimental approach to identify miRNA targets in human cells hsa-miR-17 ZNFX1 2009 A high throughput experimental approach to identify miRNA targets in human cells hsa-miR-17 PKD2 2009 MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation. hsa-miR-17-3p T¦ĀRII 2007 Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. hsa-miR-17-3p vimentin 2009 MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection hsa-miR-17-5p BMPR2 2009 Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. hsa-miR-17-5p CCND1 2008 A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. hsa-miR-17-5p BIM 2008 Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM hsa-miR-17-5p p21 2008 Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM hsa-miR-17-5p E2F1 2008 Deregulated expression of miR-106a predicts survival in human colon cancer patients. hsa-miR-17-5p PTPRO 2008 Protein tyrosine phosphatase receptor-type O (PTPRO) is co-regulated by E2F1 and miR-17-92. hsa-miR-17-5p T¦ĀRII 2007 Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. hsa-miR-17-5p AIB1 2006 Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. hsa-miR-18 CTGF 2006 Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. hsa-miR-18 RANKL 2006 Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. hsa-miR-181a CDX2 2009 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-miR-181a GATA6 2009 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-miR-181a NLK 2009 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-miR-181a PLAG1 2009 miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. hsa-miR-181a BDNF 2009 microRNAs miR-124, let-7d and miR-181a regulate Cocaine-induced Plasticity hsa-miR-181a D3R 2009 microRNAs miR-124, let-7d and miR-181a regulate Cocaine-induced Plasticity hsa-miR-181a PCAF 2008 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. hsa-miR-181b CDX2 2009 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-miR-181b GATA6 2009 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-miR-181b NLK 2009 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-miR-181b PLAG1 2009 miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. hsa-miR-181b PCAF 2008 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. hsa-miR-181b AID 2008 miR-181b negatively regulates activation-induced cytidine deaminase in B cells hsa-miR-181b Tcl1 2006 Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. hsa-miR-181c CDX2 2009 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-miR-181c GATA6 2009 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-miR-181c NLK 2009 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-miR-182 FOXO1 2009 Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells. hsa-miR-183 Ezrin 2008 MicroRNA-183 regulates Ezrin expression in lung cancer cells. hsa-miR-184 NFAT1 2009 MicroRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T-cells hsa-miR-186 P2X7 2008 MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript hsa-miR-189 SLITRK1 2008 Sequence variants in SLITRK1 are associated with Tourette's syndrome. hsa-miR-18a* KRAS 2009 The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras hsa-miR-18a* KRAS 2009 The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. hsa-miR-19 ATXN1 2008 miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. hsa-miR-192 CDKN1A/p21 2009 MicroRNA alterations in head and neck squamous cell carcinoma. hsa-miR-192 MIP-2 alpha 2008 MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. hsa-miR-193a E2F6 2008 Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. hsa-miR-193b CCND1 2010 MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. hsa-miR-195 CCND1 2009 MicroRNA-195 suppresses tumorigenicity and regulates G(1)/S transition of human hepatocellular carcinoma cells. hsa-miR-195 CDK6 2009 MicroRNA-195 suppresses tumorigenicity and regulates G(1)/S transition of human hepatocellular carcinoma cells. hsa-miR-195 E2F3 2009 MicroRNA-195 suppresses tumorigenicity and regulates G(1)/S transition of human hepatocellular carcinoma cells. hsa-miR-195 WEE1 2009 microRNAs regulate human embryonic stem cell division hsa-miR-196a KRT5 2009 MicroRNA-196a is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus. hsa-miR-196a S100A9 2009 MicroRNA-196a is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus. hsa-miR-196a SPRR2C 2009 MicroRNA-196a is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus. hsa-miR-196a HOXC8 2009 miR-196a Regulates Proliferation and Osteogenic Differentiation in Mesenchymal Stem Cells Derived From Human Adipose Tissue hsa-miR-196a ANXA1 2008 MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. hsa-miR-196a BMP4 2010 MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. hsa-miR-196a-2 HOXB8 2009 Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. hsa-miR-197 FUS1 2009 miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. hsa-miR-197 ACVR1 2006 A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. hsa-miR-197 TSPAN3 2006 A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. hsa-miR-199 ET-1 2009 Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199 hsa-miR-199a IKK-beta 2008 Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. hsa-miR-199a* Smad1 2009 miR-199a*, a bone morphogenic protein 2 responsive microRNA, regulates chondrogenesis via direct targeting to Smad1 hsa-miR-199a* ERK2 2008 MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). hsa-miR-199a* MET 2008 MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). hsa-miR-199b SET 2010 Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. hsa-miR-199b-5p HES1 2009 MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. hsa-miR-19a PTEN 2008 Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. hsa-miR-19a BIM 2008 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. hsa-miR-19a SOCS-1 2008 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. hsa-miR-19b BIM 2008 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. hsa-miR-19b SOCS-1 2008 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. hsa-miR-200a beta-catenin 2009 "Down-regulated microRNA-200a in Meningiomas Promotes Tumor Growth by Reducing E-cadherin and Activating the Wnt/{beta} catenin Signaling Pathway. hsa-miR-200a Dlx5 2009 MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse Pre-osteoblast differentiation by targeting distal-less homeobox 5 hsa-miR-200a SIP1/ZEB2 2008 A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition hsa-miR-200a ZEB1/deltaEF1 2008 A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition hsa-miR-200a SIP1(ZEB2) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-200a ZEB1(deltaEF1) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-200a SIP1(ZEB2) 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. hsa-miR-200a ZEB1(deltaEF1) 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. hsa-miR-200a WAVE3 2009 The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion hsa-miR-200a ZEB1 2009 Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition hsa-miR-200a ZEB2 2009 Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition hsa-miR-200b SIP1/ZEB3 2008 A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition hsa-miR-200b ZEB1/deltaEF1 2008 A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition hsa-miR-200b SIP1(ZEB2) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-200b ZEB1(deltaEF1) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-200b SIP1(ZEB2) 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. hsa-miR-200b ZEB1(deltaEF1) 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. hsa-miR-200b PTPN12 2006 Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. hsa-miR-200b WAVE3 2009 The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion hsa-miR-200b ZEB1 2009 E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. hsa-miR-200b ZEB2 2009 E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. hsa-miR-200b ZEB1 2009 Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition hsa-miR-200b ZEB2 2009 Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition hsa-miR-200c BMI1 2009 Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. hsa-miR-200c TUBB3 2009 MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. hsa-miR-200c E-cadherin 2009 Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression hsa-miR-200c ZEB1 2009 Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression hsa-miR-200c ZEB1(deltaEF1) 2008 A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. hsa-miR-200c SIP1(ZEB2) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-200c ZEB1(deltaEF1) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-200c SIP1(ZEB2) 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. hsa-miR-200c ZEB1(deltaEF1) 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. hsa-miR-200c ZEB1 2009 E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. hsa-miR-200c ZEB2 2009 E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. hsa-miR-200c ZEB1 2009 Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition hsa-miR-200c ZEB2 2009 Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition hsa-miR-203 p63 2008 A skin microRNA promotes differentiation by repressing 'stemness'. hsa-miR-203 ABL1 2008 Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. hsa-miR-203 ABL1 2008 Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. hsa-miR-203 BCR-ABL1 2008 Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. hsa-miR-203 BCR-ABL1 2008 Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. hsa-miR-203 SOCS-3 2007 MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis? hsa-miR-204 BCL2 2009 MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. hsa-miR-204 Mcl-1 2009 p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. hsa-miR-204 HOXA10 2008 Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. hsa-miR-204 MEIS1 2008 Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. hsa-miR-204 PDEF 2008 MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. hsa-miR-205 LRP1 2009 MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1 hsa-miR-205 HER3 2009 microRNA-205 regulates HER3 in human breast cancer. hsa-miR-205 SHIP2 2009 MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia hsa-miR-205 SIP1(ZEB2) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-205 ZEB1(deltaEF1) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-206 MET 2009 "The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation." hsa-miR-206 c-Met 2009 MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. hsa-miR-206 ER-alpha 2008 miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. hsa-miR-206 ER-alpha 2007 The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. hsa-miR-206 NOTCH3 2009 MICRORNA-206 targets NOTCH3, activates apoptosis, inhibits tumor cell migration and foci formation hsa-miR-208 THRAP1 2007 Control of stress-dependent cardiac growth and gene expression by a microRNA. hsa-miR-20a BMPR2 2009 Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. hsa-miR-20a E2F1 2009 miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression hsa-miR-20a CCND1 2008 A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. hsa-miR-20a CDKN1A 2008 MicroRNA-17-92 downregulates expression of distinct targets in different B-cell lymphoma subtypes. hsa-miR-20a p21 2008 MicroRNA-17-92 downregulates expression of distinct targets in different B-cell lymphoma subtypes. hsa-miR-20b Mylip 2006 Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. hsa-miR-21 LRRFIP1 2009 MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. hsa-miR-21 PTEN 2009 Cholesteatoma Growth and Proliferation: Posttranscriptional Regulation by MicroRNA-21. hsa-miR-21 PDCD4 2009 Cholesteatoma Growth and Proliferation: Posttranscriptional Regulation by MicroRNA-21. hsa-miR-21 PDCD4 2009 MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. hsa-miR-21 BMPRII 2009 BMPRII is a direct target of miR-21 hsa-miR-21 PDCD4 2009 An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation hsa-miR-21 PTEN 2009 An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation hsa-miR-21 REST 2009 Is REST a regulator of pluripotency? hsa-miR-21 PDCD4 2009 Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. hsa-miR-21 JAG1 2009 MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the co-ordinate regulation of dendritic cell differentiation hsa-miR-21 WNT1 2009 MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the co-ordinate regulation of dendritic cell differentiation hsa-miR-21 PDCD4 2009 MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. hsa-miR-21 Spry1 2009 MicroRNA-143 as a Tumor Suppressor for Bladder Cancer. hsa-miR-21 RECK 2009 MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. hsa-miR-21 MARCKS 2009 MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. hsa-miR-21 PDCD4 2009 MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. hsa-miR-21 LRRFIP1 2009 MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. hsa-miR-21 BASP1 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 DERL1 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 Maspin 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 NCAPG 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 PDCD4 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 PDHA2 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 PLOD3 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 PTEN 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 RPS7 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 RTN4 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 TM9SF3 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 TPM1 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 Vector 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 WFS1 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 WIBG 2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression hsa-miR-21 BTG2 2009 Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. hsa-miR-21 PTEN 2009 Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes hsa-miR-21 PDCD4 2009 Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion. hsa-miR-21 PDCD4 2008 An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation hsa-miR-21 PTEN 2008 Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. hsa-miR-21 RECK 2008 MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. hsa-miR-21 TIMP3 2008 MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. hsa-miR-21 PDCD4 2008 MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. hsa-miR-21 PDCD4 2008 MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. hsa-miR-21 HNRPK 2008 MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. hsa-miR-21 TAp63 2008 MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. hsa-miR-21 TGF-beta 2008 MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. hsa-miR-21 SPRY2 2008 MicroRNA-21 Targets Sprouty2 and Promotes Cellular Outgrowths. hsa-miR-21 maspin 2008 MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. hsa-miR-21 PDCD4 2008 MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. hsa-miR-21 TPM1 2008 MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. hsa-miR-21 BCL2 2007 MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. hsa-miR-21 PTEN 2007 MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. hsa-miR-21 PTEN 2007 MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. hsa-miR-21 TPM1 2007 MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). hsa-miR-21 BCL2 2007 miR-21-mediated tumor growth. hsa-miR-21 PDCD4 2007 Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. hsa-miR-21 PTEN 2006 Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. hsa-miR-21 PDCD4 2006 MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. hsa-miR-21 PDCD4 2009 Pdcd4, a colon cancer prognostic that is regulated by a microRNA hsa-miR-21 p53 2009 Distinct microRNA alterations characterize high- and low-grade bladder cancer hsa-miR-21 Cdc25A 2009 microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells hsa-miR-210 RAD52 2009 MicroRNA regulation of DNA repair gene expression in hypoxic stress hsa-miR-210 Ephrin-A3 2008 MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. hsa-miR-210 ISCU1/2 2009 MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2 hsa-miR-210 FGFRL1 2009 Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation hsa-miR-210 HOXA1 2009 Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation hsa-miR-210 PIM1 2009 Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation hsa-miR-210 TP53I11 2009 Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation hsa-miR-210 HOXA9 2009 Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation hsa-miR-212 ZO-1 2008 Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. hsa-miR-214 PTEN 2008 MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. hsa-miR-214 Ezh2 2009 Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells hsa-miR-214 MEK3 2009 MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells hsa-miR-214 JNK1 2009 MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells hsa-miR-215 CDKN1A/p21 2009 MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. hsa-miR-216a PTEN 2009 TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN hsa-miR-217 PTEN 2009 TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN hsa-miR-217 SirT1 2009 MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1 hsa-miR-218 LAMB3 2008 Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. hsa-miR-219 CaMKIIgamma 2009 MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction hsa-miR-22 ERalpha 2009 miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. hsa-miR-221 Bmf 2009 MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. hsa-miR-221 p27 2009 A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia hsa-miR-221 p27 2009 Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. hsa-miR-221 p27(Kip1) 2009 Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. hsa-miR-221 p27 2009 Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. hsa-miR-221 p57 2009 Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. hsa-miR-221 c-KIT 2009 Induction of MicroRNA-221 by Platelet-derived Growth Factor Signaling Is Critical for Modulation of Vascular Smooth Muscle Phenotype hsa-miR-221 p27Kip1 2009 Induction of MicroRNA-221 by Platelet-derived Growth Factor Signaling Is Critical for Modulation of Vascular Smooth Muscle Phenotype hsa-miR-221 Bim 2009 Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells hsa-miR-221 c-KIT 2009 The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. hsa-miR-221 CDKN1B/p27/Kip1 2008 MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. hsa-miR-221 KIT 2008 MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. hsa-miR-221 c-KIT 2008 MicroRNA-221 and -222 pathway controls melanoma progression. hsa-miR-221 p27(Kip1) 2008 MicroRNA-221 and -222 pathway controls melanoma progression. hsa-miR-221 p27(Kip1) 2008 MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1. hsa-miR-221 ERalpha 2008 MicroRNA-221/222 Negatively Regulates Estrogen Receptor{alpha} and Is Associated with Tamoxifen Resistance in Breast Cancer. hsa-miR-221 CDKN1B/p27/Kip1 2008 MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. hsa-miR-221 CDKN1C/p57 2008 MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. hsa-miR-221 CDKN1B/p27/Kip1 2008 The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. hsa-miR-221 c-KIT 2008 The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. hsa-miR-221 KIT 2008 The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. hsa-miR-221 BIRC1 2008 Up-regulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1 (NAIP) in glioblastoma multiforme (GBM). hsa-miR-221 CDKN1B/p27/Kip1 2007 miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. hsa-miR-221 CDKN1B/p27/Kip1 2007 Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. hsa-miR-221 KIT 2005 The role of microRNA genes in papillary thyroid carcinoma. hsa-miR-221 p27 2009 Microrna-221 and microrna-222 modulate differentiation and maturation of skeletal muscle cells hsa-miR-221 CDKN1B 2009 miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221 hsa-miR-222 p27 2009 A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia hsa-miR-222 p27 2009 Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. hsa-miR-222 p27 2009 Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. hsa-miR-222 p57 2009 Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. hsa-miR-222 MMP1 2009 "MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1(MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines." hsa-miR-222 SOD2 2009 "MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1(MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines." hsa-miR-222 Bim 2009 Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells hsa-miR-222 CDKN1B/p27/Kip1 2008 MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. hsa-miR-222 KIT 2008 MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. hsa-miR-222 c-KIT 2008 MicroRNA-221 and -222 pathway controls melanoma progression. hsa-miR-222 p27(Kip1) 2008 MicroRNA-221 and -222 pathway controls melanoma progression. hsa-miR-222 p27(Kip1) 2008 MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1. hsa-miR-222 ERalpha 2008 MicroRNA-221/222 Negatively Regulates Estrogen Receptor{alpha} and Is Associated with Tamoxifen Resistance in Breast Cancer. hsa-miR-222 CDKN1C/p57 2008 MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell Survival. hsa-miR-222 CDKN1B/p27/Kip1 2008 The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. hsa-miR-222 c-KIT 2008 The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. hsa-miR-222 KIT 2008 The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. hsa-miR-222 CDKN1B/p27/Kip1 2007 miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. hsa-miR-222 CDKN1B/p27/Kip1 2007 Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. hsa-miR-222 KIT 2005 The role of microRNA genes in papillary thyroid carcinoma. hsa-miR-222 p27 2009 Microrna-221 and microrna-222 modulate differentiation and maturation of skeletal muscle cells hsa-miR-223 LMO2 2009 MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis hsa-miR-223 STMN1 2008 MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. hsa-miR-223 Mef2c 2008 Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. hsa-miR-223 NFI-A 2007 Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. hsa-miR-223 RhoB 2009 Sequence context outside the target region influences the effectiveness of miR-223 target sites in the RhoB 3'UTR hsa-miR-224 API-5 2008 Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. hsa-miR-23 LMNB1 2009 miR-23 regulation of lamin B1 is crucial for oligodendrocyte development and myelination hsa-miR-23a RING1 2009 miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. hsa-miR-23b MOR1 2009 MicroRNA-dependent regulation of cKit in cutaneous melanoma. hsa-miR-23b MOR1 2008 Post-transcriptional regulation of mouse {micro} opioid receptor (MOR1) via its 3' untranslated region: a role for microRNA23b hsa-miR-24 L protein 2007 Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. hsa-miR-24 P protein 2007 Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. hsa-miR-24 DHFR 2004 A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. hsa-miR-24 E2F2 2009 miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements hsa-miR-24 MYC 2009 miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements hsa-miR-24 AURKB 2009 miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements hsa-miR-24 CCNA2 2009 miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements hsa-miR-24 CDC2 2009 miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements hsa-miR-24 CDK4 2009 miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements hsa-miR-24 FEN1 2009 miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements hsa-miR-24a apaf1 2009 microRNA-24a is required to repress apoptosis in the developing neural retina hsa-miR-24a Casp9 2009 microRNA-24a is required to repress apoptosis in the developing neural retina hsa-miR-25 p57 2009 Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. hsa-miR-25 Bim 2009 Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. hsa-miR-25 PCAF 2008 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. hsa-miR-26a PTEN 2009 The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. hsa-miR-26a CCND2 2009 Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. hsa-miR-26a CCNE2 2009 Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. hsa-miR-26a EZH2 2008 MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. hsa-miR-26a HMGA1 2007 Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. hsa-miR-26a HMGA2 2007 Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. hsa-miR-27 Runx1 2009 MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1 hsa-miR-27a FOXO1 2009 Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells. hsa-miR-27a Runx1 2009 A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis hsa-miR-27a prohibitin 2009 miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. hsa-miR-27a Myt-1 2007 The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. hsa-miR-27a ZBTB10 2007 The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. hsa-miR-27b PPARgamma 2009 microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamm hsa-miR-296 HGS 2008 miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. hsa-miR-298 BACE1 2009 MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. hsa-miR-298 BACE1 2008 MicroRNA-298 and microRNA-328 regulate expression of mouse beta -amyloid precursor protein converting enzyme 1. hsa-miR-29a B7-H3 2009 MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. hsa-miR-29a BACE1 2008 Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. hsa-miR-29a DNMT3A 2007 MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. hsa-miR-29a DNMT3B 2007 MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. hsa-miR-29b ACVR2A 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b ACVR2A 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b COL1A1 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b COL4A2 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b COL5A3 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b CTNNBIP1 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b CTNNBIP1 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b HDAC4 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b HDAC4 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b TGFss3 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b TGFss3 2009 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation hsa-miR-29b DNMT3B 2009 Detection of miR-106a in gastric carcinoma and its clinical significance. hsa-miR-29b Sp1 2009 Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. hsa-miR-29b DNMT3A 2009 MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse {beta}-Amyloid Precursor Protein-converting Enzyme 1. hsa-miR-29b BACE1 2008 Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. hsa-miR-29b DNMT3A 2007 MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. hsa-miR-29b DNMT3B 2007 MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. hsa-miR-29b Mcl-1 2007 mir-29 regulates Mcl-1 protein expression and apoptosis. hsa-miR-29b Tcl1 2007 The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. hsa-miR-29b Tcl1 2006 Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. hsa-miR-29b Mcl-1 2009 MicroRNA 29b functions in acute myeloid leukemia hsa-miR-29c COL15A1 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. hsa-miR-29c COL1A1 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. hsa-miR-29c COL1A2 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. hsa-miR-29c COL3A1 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. hsa-miR-29c COL4A1 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. hsa-miR-29c COL4A2 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. hsa-miR-29c FUSIP1iso1 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. hsa-miR-29c LAMININ gamma1 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. hsa-miR-29c SPARC 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. hsa-miR-29c TDG 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. hsa-miR-29c DNMT3A 2007 MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. hsa-miR-29c DNMT3B 2007 MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. hsa-miR-302d KLF13 2009 Target identification of microRNAs expressed highly in human embryonic stem cells hsa-miR-302d MBNL2 2009 Target identification of microRNAs expressed highly in human embryonic stem cells hsa-miR-302d TRPS1 2009 Target identification of microRNAs expressed highly in human embryonic stem cells hsa-miR-30-3p KRT7 2009 Identification of novel microRNA targets based on microRNA signatures in bladder cancer. hsa-miR-30a beclin 1 2009 Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells hsa-miR-30e Ubc9 2009 MicroRNA-mediated regulation of Ubc9 expression in cancer cells hsa-miR-31 RhoA 2009 A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. hsa-miR-31 FOXP3 2009 Human natural Treg microRNA signature: Role of microRNA-31 and microRNA-21 in FOXP3 expression hsa-miR-32 PCAF 2008 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. hsa-miR-320 Hsp20 2009 MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. hsa-miR-320 TfR-1 2009 Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. hsa-miR-320 Mcl-1 2009 Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase, Itch for degradation. hsa-miR-320 BCL2 2009 The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. hsa-miR-320 CD71 2008 The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. hsa-miR-324-5p Gli1 2008 Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. hsa-miR-326 Gli1 2008 Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. hsa-miR-328 ABCG2 2009 MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells. hsa-miR-328 BACE1 2009 MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. hsa-miR-328 CD44 2008 MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. hsa-miR-328 BACE1 2008 MicroRNA-298 and microRNA-328 regulate expression of mouse beta -amyloid precursor protein converting enzyme 1. hsa-miR-330 E2F1 2009 MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. hsa-miR-335 SOX4 2008 Endogenous human microRNAs that suppress breast cancer metastasis. hsa-miR-338 COXIV 2009 MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons hsa-miR-34 SIRT1 2009 MiR-34, SIRT1 and p53: the feedback loop hsa-miR-346 EFEMP2 2006 A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. hsa-miR-346 RIP140 2009 An Epigenetic Switch Involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation hsa-miR-34a BCL2 2009 miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. hsa-miR-34a JAG1 2009 MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the co-ordinate regulation of dendritic cell differentiation hsa-miR-34a WNT1 2009 MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the co-ordinate regulation of dendritic cell differentiation hsa-miR-34a c-Met 2009 MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. hsa-miR-34a c-Met 2009 miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. hsa-miR-34a BCL2 2008 A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. hsa-miR-34a MYCN 2008 A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. hsa-miR-34a E2F3 2008 Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. hsa-miR-34a NOTCH1 2008 Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. hsa-miR-34a SIRT1 2008 Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. hsa-miR-34a GRM7 2008 Evidence for Selective microRNAs and their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers hsa-miR-34a SIRT1 2008 MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. hsa-miR-34a c-Met 2008 The cell growth suppressor, mir-126, targets IRS-1. hsa-miR-34a MYCN 2008 The MYCN oncogene is a direct target of miR-34a. hsa-miR-34a E2F 2007 MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. hsa-miR-34a E2F3 2007 MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. hsa-miR-34a BCL2 2007 p53-mediated activation of miRNA34 candidate tumor-suppressor genes. hsa-miR-34a BCL2 2007 Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. hsa-miR-34a BIRC3 2007 Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. hsa-miR-34a DcR3 2007 Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. hsa-miR-34a E2F 2007 Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. hsa-miR-34a c-Met 2009 MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes hsa-miR-34a Notch-1 2009 MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes hsa-miR-34a Notch-2 2009 MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes hsa-miR-34a CDK6 2009 MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes hsa-miR-34b CREB 2009 miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. hsa-miR-34b CDK6 2008 A microRNA DNA methylation signature for human cancer metastasis hsa-miR-34b c-myc 2008 A microRNA DNA methylation signature for human cancer metastasis hsa-miR-34b c-myc 2008 MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. hsa-miR-34b BCL2 2007 p53-mediated activation of miRNA34 candidate tumor-suppressor genes. hsa-miR-34c c-myc 2008 A microRNA DNA methylation signature for human cancer metastasis hsa-miR-34c E2F3 2008 A microRNA DNA methylation signature for human cancer metastasis hsa-miR-34c BCL2 2007 p53-mediated activation of miRNA34 candidate tumor-suppressor genes. hsa-miR-34c c-Met 2010 Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. hsa-miR-370 MAP3K8 2008 Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. hsa-miR-372 KLF13 2009 Target identification of microRNAs expressed highly in human embryonic stem cells hsa-miR-372 MBNL2 2009 Target identification of microRNAs expressed highly in human embryonic stem cells hsa-miR-372 TRPS1 2009 Target identification of microRNAs expressed highly in human embryonic stem cells hsa-miR-372 LATS2 2006 A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. hsa-miR-372 WEE1 2009 microRNAs regulate human embryonic stem cell division hsa-miR-373 RAD23B 2009 MicroRNA regulation of DNA repair gene expression in hypoxic stress hsa-miR-373 LATS2 2009 "MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer." hsa-miR-373 CD44 2008 The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. hsa-miR-373 LATS2 2006 A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. hsa-miR-375 PDK1 2008 miR-375 targets PDK1 and regulates glucose-induced biological responses in pancreatic {beta}-cells. hsa-miR-375 Mtpn 2004 A pancreatic islet-specific microRNA regulates insulin secretion. hsa-miR-375 TIMM8A 2009 A high throughput experimental approach to identify miRNA targets in human cells hsa-miR-378 GalNT-7 2009 MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7 hsa-miR-424 PLAG1 2009 miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. hsa-miR-429 SIP1/ZEB4 2008 A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition hsa-miR-429 ZEB1/deltaEF1 2008 A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition hsa-miR-429 SIP1(ZEB2) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-429 ZEB1(deltaEF1) 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. hsa-miR-429 SIP1(ZEB2) 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. hsa-miR-429 ZEB1(deltaEF1) 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. hsa-miR-429 WAVE3 2009 The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion hsa-miR-429 ZEB1 2009 Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition hsa-miR-429 ZEB2 2009 Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition hsa-miR-433 FGF20 2008 Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. hsa-miR-449a HDAC-1 2009 miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. hsa-miR-451 MIF 2009 microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. hsa-miR-451 MIF 2009 microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. hsa-miR-485-3p NTRK3 2009 Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. hsa-miR-504 DRD1 2009 Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504 hsa-miR-504 DRD1 2009 Differential Allelic Expression of Dopamine D1 Receptor Gene (DRD1) Is Modulated by microRNA miR-504 hsa-miR-509 NTRK3 2009 Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. hsa-miR-510 HTR3E 2008 First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor type 3E gene with diarrhea predominant irritable bowel syndrome. hsa-miR-510 PDEF 2008 MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. hsa-miR-512-5p Mcl-1 2009 Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. hsa-miR-513 B7-H 2009 MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes hsa-miR-519 HuR 2010 miR-519 suppresses tumor growth by reducing HuR levels. hsa-miR-519c ABCG2 2009 Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2 hsa-miR-520c CD44 2008 The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. hsa-miR-520h ABCG2 2009 Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2 hsa-miR-521 CSA 2008 Radiation modulation of microRNA in prostate cancer cell lines. hsa-miR-532-5p RUNX3 2009 Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma. hsa-miR-548d-3p ERBB2 2009 Preliminary validation of ERBB2 expression regulated by miR-548d-3p and miR-559 hsa-miR-559 ERBB2 2009 Preliminary validation of ERBB2 expression regulated by miR-548d-3p and miR-559 hsa-miR-562 EYA1 2009 Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562 hsa-miR-659 GRN 2008 Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. hsa-miR-661 MTA1 2009 MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions. hsa-miR-7 SNCA 2009 Repression of alpha-synuclein expression and toxicity by microRNA-7. hsa-miR-7 EGFR 2009 MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. hsa-miR-7 EGFR 2009 MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. hsa-miR-7 EGFR 2009 MicroRNA-34a Inhibits Uveal Melanoma Cell Proliferation and Migration through Downregulation of c-Met. hsa-miR-7 EGFR 2009 Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. hsa-miR-7 EGFR 2008 microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. hsa-miR-7 Pak1 2008 MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. hsa-miR-709 BORIS 2009 DNA damage-induced upregulation of miR-709 in the germline downregulates BORIS to counteract aberrant DNA hypomethylation hsa-miR-765 NTRK3 2009 Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. hsa-miR-9 E-cadherin 2009 MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. hsa-miR-9 NF-kappaB1 2009 MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. hsa-miR-9 TLX 2009 A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination hsa-miR-9 TrkC 2009 microRNA-1 negatively regulates expression of the hypertrophy-associated genes calmodulin and Mef2a. hsa-miR-9 REST 2009 Role of miR-143 targeting KRAS in colorectal tumorigenesis. hsa-miR-9 MMP13 2009 The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13 hsa-miR-9 TrkC 2008 MicroRNA profiling in human medulloblastoma. hsa-miR-9 PRDM1/Blimp-1 2008 MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. hsa-miR-9 ONECUT-2 2006 MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. hsa-miR-9* CoREST 2009 MicroRNA profiling in human medulloblastoma. hsa-miR-92b p57 2009 MicroRNA 92b Controls the G1/S Checkpoint Gene p57 in Human Embryonic Stem Cells hsa-miR-93 FUS1 2009 miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. hsa-miR-93 p21 2009 Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. hsa-miR-93 E2F1 2009 Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. hsa-miR-93 E2F1 2008 E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. hsa-miR-93 PCAF 2008 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. hsa-miR-93 TP53INP1 2008 Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. hsa-miR-96 FOXO1 2009 Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells. hsa-miR-98 FUS1 2009 miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. hsa-miR-98 HMGA2 2007 High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.